Clinical Trial Update: Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating adjuvant carboplatin-paclitaxel for locally advanced cervical cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Locally Advanced Cancer, Cervical Cancer | Phase 2 | Status: TERMINATED